Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Esophageal Neoplasms 1Epilepsy 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1

Interventions

Radiotherapy 3Chemotherapy, Adjuvant 3Magnetic Resonance Spectroscopy 2Letrozole 2Carboplatin 2gallium 68 PSMA-11 1fluciclovine F-18 1atamestane 1Zolpidem 1Venlafaxine Hydrochloride 1Trastuzumab 1Toremifene 1Thiotepa 1Tamoxifen 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiosurgery 1Radiation 1Proton Therapy 1Paclitaxel 1Melphalan 1Mass Spectrometry 1Indocyanine Green 1Immunohistochemistry 1Histocompatibility Testing 1Gene Expression Profiling 1Fulvestrant 1Fluorescent Antibody Technique 1Estrogen Receptor Modulators 1Drugs, Generic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Lobular × Histocompatibility Testing × Clear all
NCT00581750 2021-07-02

Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ

Memorial Sloan Kettering Cancer Center

Completed
550 enrolled
Breast

Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡